Epidemiology of chronic hepatitis B in Majeedia Unani Hospital, New Delhi.
Abstract
India has HBV carrier rate of 3.0% approximately with a high prevalence rate in the villages and remote areas. The variation in social, ethnic, economic, habits and other health conditions in different areas may explain the difference in outcomes of the disease. High-risk groups (especially tribals) also harbor significant disease burden and have a high prevalence of occult infection, supporting the potential of unknowingly spreading the disease. Hence identifying and targeting those population for public healthcare measure is the necessity to control the disease and promoting hepatitis B vaccination around the country. The present study was carried to out to elucidate epidemiology of chronic hepatitis B in the patients of Majeedia Unani Hospital New Delhi to locate high risk groups and areas for health education regarding lifestyle, preventive measures, early disease detection and proper adherence to drugs and of health care workers on adoption of proper precautions while carrying out their duties, and aggressive vaccination strategies thereafter.
DOI
https://doi.org/10.22270/jddt.v9i2.2571References
World health organisation (WHO). Hepatitis B. [Internet]. 2018 [Cited 2018 August 30]. Available from: http://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
Puri P. Tackling the Hepatitis B Disease Burden in India. J Clin Exp Hepatol. 2014; 4(4):312-9.
Siddiqui MA, Ansari S, Khan QA. Socio-demographic profile of health camp on viral hepatitis B and C at Maswasi, Rampur. Middle East journal of rehabilitation of health. 2017; 2:e44359.
Schalm SW, Janssen HLA. Treatment of HBeAg-Positive Chronic Hepatitis B with Conventional or Pegylated Interferon [Internet]. 2004 [Cited 2014 Feb 10]. P. 246, 251, 254. Available from:
http://www.aphc.info/wp-content/uploads/2014/10/07PHC_Book_Chapter18.pdf.
Warner N, Stephen L. Replication of Hepatitis B Virus. In: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyers Hepatology. 6th ed. Cananda: Elsevier; 2012. P. 86-94.
Lok ASF, McMahon BJ, Brown RS, Wong JB, Ahmed TA, Farah W. Antiviral therapy for chronic hepatitis B viral infections in adults: a systematic review and metanalysis. Hepatology. 2016; 63(1):1-13.
Anna SF, LokHari SC, Negro F. Hepatitis B & D. In: Schiff ER, Sorrell MF, Maddrey WC. Schiff's Disease of the Liver. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Vol. 1. P. 745-48, 752-53-4-5, 755-759, 760-2, 763, 764, 770-79.
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD Guidelines for Treatment of Chronic Hepatitis B. American Association for the Study of Liver Diseases Practice Guidelines [Internet]. 2015 [Cited 2016 June 10]. P. 1-23. Available from:
https://www.aasld.org/sites/default/files/guideline_documents/hep28156.pdf.
Kumar M, Sarin SK. Viral hepatitis eradication in India by 2080 -gaps, challenges & targets. Indian J Med Res. 2014; 140:1-4.
Tabri ABR. Al-Moalejaat Buqratiya. New Delhi: Central Council for Research In Unani Medicine; 1997. Vol 3. P. 197-217.
Ibne Sina (Avicenna). Al-Qanoon Fit-Tibb [Kantoori GH, Trans]. New Delhi: Aijaz Publishing; 2010. Vol 3, part 1. P. 854-854-859-862, 869-78.
Jurjani AH. Zakheera khwarzim shahi, [Khan HH, Trans]. Lucknow: Munshi Nawal Kishore publishing. Vol 2. Part 7. P. 368-382.
Khan H, Ikseere Azam [H. Kabiruddin, Trans]. New Delhi: Aijaz Publishing; 2010. P. 489, 505-515.
Razi AB. Kitabul-Hawi [Urdu translation]. New Delhi: Central council for research in Unani Medicine; 2000. Vol 7. P. 47-50, 52-73, 119-145.
Lok ASF, McMahon BJ. Correction to AASLD Practice Guideline: Chronic Hepatitis B [Internet]. 2007 [Cited 2014 March 20]. Available from:
file:///D:/HBV/Corrections%20to%20Guidelines%20on%20Chronic%20Hep%20B%20aasld.pdf
Kumar M, Sarin SK. Viral hepatitis eradication in India by 2080 -gaps, challenges & targets. Indian J Med Res. 2014;140:1-4.
Warner N, Stephen L. Replication of Hepatitis B Virus. In: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyers Hepatology. 6th ed. Cananda: Elsevier; 2012. P. 86-94.
Published
Abstract Display: 1211 
PDF Downloads: 811 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.